Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.
作者:
关键词
BioavailabilityCarboxylated chitosan (PubChem CID: 4295892)Carboxymethylcellulose sodium (PubChem CID: 6328154)Cremophor ELP (PubChem CID: 68516)DaidzeinDaidzein (PubChem CID: 5281708)Electrostatic stabilizersEthyl acetate (PubChem CID: 8857)NanosuspensionPoloxamer 188 (PubChem CID: 24751)Polyethylene glycol 600 (PubChem CID: 174)Polyvinyl pyrrolidone K30 (PubChem CID: 6917)Sodium dodecyl sulfate (PubChem CID: 3423265)SolubilitySoy lecithin (PubChem CID: 5287971)Steric stabilizers
主题词
投药, 口服(Administration, Oral);动物(Animals);生物利用度(Biological Availability);Caco-2细胞(Caco-2 Cells);细胞存活(Cell Survival);药物调剂(Drug Compounding);人类(Humans);异黄酮类(Isoflavones);男(雄)性(Male);纳米粒子(Nanoparticles);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);溶解度(Solubility);悬液(Suspensions)
DOI
10.1016/j.ijpharm.2019.05.051
PMID
31125715
发布时间
2019-12-17
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文